Research output per year
Research output per year
Research output
- 22 results
Search results
-
2014
Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model
Nur, H., Rao, L., Vacca, A., Elewaut, D., Van Valckenborgh, E., De Bruyne, E., Vanderkerken, K. & Menu, E., 1 Feb 2014, In: Belgian Journal of Hematology. 2014, p. 24-25 2 p.Research output: Contribution to journal › Conference paper
-
The in vivo Transcriptional Response Towards Epigenetic Modulating Agents in Multiple Myeloma
Maes, K., De Smedt, E., Kassambara, A., Hose, D., Seckinger, A., Van Valckenborgh, E., Menu, E., Klein, B., Vanderkerken, K., Moreaux, J. & De Bruyne, E., 6 Dec 2014, In: Blood. 124, 21, p. 3375 1 p.Research output: Contribution to journal › Conference paper
-
2013
Epigenetic regulation of hematological malignancies
De Bruyne, E., 24 Jan 2013, In: Belgian Journal of Hematology. 2013, p. 10-11 2 p.Research output: Contribution to journal › Conference paper
-
Invariant Natural Killer T cells in the 5T33 multiple myeloma model
Nur, H., Fostier, K., Aspeslagh, S., Renmans, W., Bertrand, E., Leleu, X., Breckpot, K., Schots, H., De Waele, M., Van Valckenborgh, E., De Bruyne, E., Facon, T., Elewaut, D., Vanderkerken, K. & Menu, E., 24 Jan 2013, In: Belgian Journal of Hematology. 2013, p. 26-26 1 p.Research output: Contribution to journal › Conference paper
24 Citations (Scopus) -
Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model.
Lemaire, M., Muyldermans, S., Lahoutte, T., Menu, E., Van Valckenborgh, E., De Bruyne, E., Devoogdt, N. & Vanderkerken, K., 24 Jan 2013, In: Belgian Journal of Hematology. 2013, p. 14-14 1 p.Research output: Contribution to journal › Conference paper
-
The generation and activation of myeloid-derived suppressor cells in multiple myeloma.
De Veirman, K., De Bruyne, E., Menu, E., Van Riet, I., Vanderkerken, K. & Van Valckenborgh, E., 24 Jan 2013, In: Belgian Journal of Hematology. 2013, p. 28-28 1 p.Research output: Contribution to journal › Conference paper
-
The IGF-1 receptor inhbitor picropodophyllin (PPP) potentiates the anti-myeloma effects of the BH3 mimetic ABT-737.
Bieghs, L., Maes, K., Van Valckenborgh, E., Menu, E., Overgaard, M., Johnsen, H., Nyegaard, M., Fostier, K., Schots, H., Larsson, O., Jernberg-Wiklund, H., Vanderkerken, K. & De Bruyne, E., 24 Jan 2013, In: Belgian Journal of Hematology. 2013, p. 26-26 1 p.Research output: Contribution to journal › Conference paper
-
2012
Combination of the IGF-1 Receptor Inhibitor Picropodophylin and the BH3 Mimetic ABT-737 Has Synergistic Anti-Myeloma Activity
Bieghs, L., Maes, K., Van Valckenborgh, E., Menu, E., Johnsen, H., Nyegaard, M., Jernberg-Wiklund, H., Vanderkerken, K. & De Bruyne, E., Dec 2012, In: Blood. 120, 21, p. 4010-4010 1 p.Research output: Contribution to journal › Conference paper
-
Dll1/Notch Interaction Contributes to a Decreased Sensitivity of Myeloma Cells to Bortezomib
Xu, D., Hu, J., De Bruyne, E., Menu, E., Schots, H., Vanderkerken, K. & Van Valckenborgh, E., Dec 2012, In: Blood. 120, 21, p. 1840-1840 1 p.Research output: Contribution to journal › Conference paper
-
Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model
Nur, H., Aspeslagh, S., Van Valckenborgh, E., De Bruyne, E., Elewaut, D., Vanderkerken, K. & Menu, E., Dec 2012, In: Blood. 120, 21, p. 938-938 1 p.Research output: Contribution to journal › Conference paper
-
The DNA Methyltransferase Inhibitor Decitabine Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Multiple Myeloma
Maes, K., Lemaire, M., Gauthier, J., De Raeve, H., Menu, E., Van Valckenborgh, E., Jernberg-Wiklund, H., Vanderkerken, K. & De Bruyne, E., Dec 2012, In: Blood. 120, p. 1833-1833 1 p.Research output: Contribution to journal › Conference paper
-
2011
Bone marrow endothelial cells as active players in the pathobiology of multiple myeloma
Vanderkerken, K., De Bruyne, E., Menu, E., Van Valckenborgh, E. & Van Camp, B., 1 Jan 2011, In: Bone. 48, 2011, p. 7-8 2 p.Research output: Contribution to journal › Conference paper
-
Combination of decitabine and JNJ-26481585 triggers synergistic anti-myeloma activity
Maes, K., Lemaire, M., Arts, J., Van Valckenborgh, E., Menu, E., De Raeve, H., Jernberg-Wiklund, H., Van Riet, I., Vanderkerken, K. & De Bruyne, E., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 111-111 1 p.Research output: Contribution to journal › Conference paper
-
Dll1/NOTCH interaction induces drug resistance to Bortezomib by two distinct mechanism in Multiple Myeloma
Xu, D., Hu, J., De Bruyne, E., Menu, E., Van Camp, B., Vanderkerken, K. & Van Valckenborgh, E., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 36-36 1 p.Research output: Contribution to journal › Conference paper
-
Epigenetic changes of Myeloma cells within the bone marrow microenvironment
Vanderkerken, K., De Bruyne, E., Lemaire, M., Maes, K., Deleu, S., Menu, E., Van Valckenborgh, E., Van Camp, B., Xu, S., Jernberg-Wiklund, H. & Van Riet, I., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 8-9 2 p.Research output: Contribution to journal › Conference paper
9 Citations (Scopus) -
Functional properties of CD138- and CD138+ cells in Multiple Myeloma: Study in the 5T33MM model
Van Valckenborgh, E., Lub, S., Xu, D., De Bruyne, E., Menu, E., Agarwal, P., Jernberg-Wiklund, H. & Vanderkerken, K., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 34-34 1 p.Research output: Contribution to journal › Conference paper
-
NKT cells in Multiple Myeloma: a useful therapeutic tool?
Menu, E., Nur, H., Van Valckenborgh, E., De Bruyne, E., Elewaut, D. & Vanderkerken, K., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 111-111 1 p.Research output: Contribution to journal › Conference paper
-
Synergistic cytotoxicity effects of TH-302 in combination with Bortezomib in Multiple Myeloma.
Hu, J., Van Valckenborgh, E., Dang, N., Menu, E., De Raeve, H., Xu, D., Xu, S., De Bruyne, E., Handisides, D. R., Van Camp, B., Hart, C. & Vanderkerken, K., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 112-112 1 p.Research output: Contribution to journal › Conference paper
-
The HDAC inhibitor LBH589 enhances the anti-myeloma effect of the IGF-1 RTK inhibitor picropodophyllin (PPP)
Lemaire, M., Fristedt, C., Agarwal, P., Menu, E., Van Valckenborgh, E., De Bruyne, E., Atadja, P., Van Camp, B., Jernberg-Wiklund, H. & Vanderkerken, K., 2 May 2011, In: Haematologica: the Haematology Journal. 96, 2011, p. 112-112 1 p.Research output: Contribution to journal › Conference paper
-
2010
Epigenetics of multiple myeloma cells within their bone marrow microenvironment as therapeutic targets.
Vanderkerken, K., Maes, K., Deleu, S., Lemaire, M., Menu, E., Van Valckenborgh, E., Bos, T., Van Camp, B., Jernberg-Wiklund, H. & De Bruyne, E., 2010, In: International Journal of Molecular Medicine. 26, 2010, p. 23-23 1 p.Research output: Contribution to journal › Conference paper
-
Involvement of Dll1/Notch Interaction In MM Drug Resistance, Clonogenic Growth and In Vivo Engraftment
Xu, D., Hu, J., De Bruyne, E., Menu, E., Van Camp, B., Vanderkerken, K. & Van Valckenborgh, E., 19 Nov 2010, In: Blood. 116, 21, p. 1223-1223 1 p.Research output: Contribution to journal › Conference paper
-
Multiple myeloma cells antagonize hypoxia induced cell death through upregulation bcl-2 and bcl-xl
Hu, J., Van Valckenborgh, E., Menu, E., De Bruyne, E., Xu, D., Van Camp, B. & Vanderkerken, K., 1 May 2010, In: Haematologica. 95, 2010, p. 138-138 1 p.Research output: Contribution to journal › Conference paper